2025 Spring International Convention of
The Pharmaceutical Society of Korea

2025 Spring
International Convention of PSK

04.21(MON) - 04.22(TUE)
D-37

Abstracts

P10-2

Associated Factors and Outcomes of a Multidisciplinary Team-Based Polypharmacy Management Program in South Korea

  • Hyunwoo Chae1, Young-Mi Ah2, Sunmee Jang3, Suhyun Jang3, Hye Jun Lee4, Jung-Ha Kim*4, Ju-Yeun Lee*1,5
  • 1College of Pharmacy, Seoul National Univerisity, Seoul, Republic of Korea
  • 2College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, Republic of Korea
  • 3College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, Republic of Korea
  • 4Department of Family Medicine, Chung-Ang University Medical Center, Chung-Ang University College of Medicine, Seoul, Republic of Korea
  • 5Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea

Introduction

The hospital-based polypharmacy management program (PMP) was implemented in South to address polypharmacy-related concerns among older adults. In this study, we aimed to assess the initial outcomes of the program and identify factors associated with medication-related problems (MRPs) that led to prescription modifications.

Methods

We analyzed data from 1,740 PMP participants in 2021. Medication review records, intervention outcome records, and patient demographics were examined. MRPs were identified, classified, and documented alongside prescription modifications. To determine factors influencing prescription changes, we conducted multivariable logistic regression analysis.

Results

Among the study population, 73.5% (1,279 patients) had at least one MRP, with total of 4,631 MRPs identified. The most common MRPs were the use of potentially inappropriate medications (58.7%), drug interactions (46.9%), and adverse drug reactions (26.2%). Pharmacists recommended prescription modifications in 32.4% of MRPs, with an acceptance rate of 92.2%. Factors significantly associated with pharmacist interventions included advanced age (aOR 2.4 for ≥85 years), polypharmacy (aOR 2.3 for patients taking ≥20 medications), and the use of specific drug classes, such as anticholinergics, oral hypoglycemic agents, and proton pump inhibitors.

Conclusion

The hospital-based PMP effectively identified and addressed MRPs. Key factors influencing prescription modifications-such as polypharmacy, older age, and the use of specific medication classes-can serve as a strategic approach for selecting the target population that would benefit most from PMP. Further research is necessary to assess the long-term effects of the program on clinical outcomes and healthcare expenditures.


Q&A

작성하기
  • There are no registered questions
TODAY 2025. 03. 15

2025 Spring Convention

D-37

Conference infomation

Conference Schedule
Apr. 21(Mon) ~ 22(Tue), 2025
Conference Venue
Daegu Exhibition & Convention Center (EXCO) 10 Exco-ro, Buk-gu, Daegu, Republic of Korea
Location
Early Registration Period
Feb. 24(Mon) ~ Mar. 21(Fri), 2025
Abstract Submission Period
Feb. 24(Mon) ~ Mar. 21(Fri), 2025
Certificate of Attendance